Inflation risks appear to be rising, threatening to throw Fed’s rate-cut hopes into disarray The possibility that U.S. inflation won’t trend much lower from here is raising concerns that Federal Reserve policymakers are mistakenly clinging to prospects for three interest-rate cuts this year and may lose their credibility, which could trigger cross-asset volatility. |
Weight loss biotech plans IPO as demand builds for anti-obesity treatments Aardvark Therapeutics’ drug has been shown in trials to suppress cravings in patients with rare genetic form of obesity |
Píše se o |